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Chronic nonhealing wounds such as diabetic ulcers are a major problem associated with 
human disease. In this issue, Liu et al. offer new hope for tackling nonhealing wounds 
by defining a novel role for the leukotriene B4 receptor type 2 (BLT2) and its ligand 
12-hydroxyheptadecatrienoic acid (12-HHT) in wound healing. They also show that high-
dose aspirin delays wound healing by reducing the levels of 12-HHT.
Endogenously produced lipid autacoids are locally 
acting, small molecule mediators that regulate diverse 
processes such as inflammation, asthma, colitis, tissue 
regeneration, and cancer. Unlike prostaglandins and 
leukotrienes, the biological roles of 12-HHT and its 
receptor BLT2 have been poorly characterized. 12-HHT, a downstream lipid metabolite 
of cyclooxygenase 1 (COX1) and COX2, was previously assumed to be an inert 
by-product of arachidonic acid metabolism until its recent identification as an endog-
enous high-affinity ligand for BLT2 by this group. It is known that high-dose aspirin, 
the most commonly used nonsteroidal anti-inflammatory drug (NSAID) targeting the 
COX pathway, delays wound healing but the mechanism by which this delay occurs 
has been poorly characterized. Most of aspirin’s pharmacological effect has been attrib-
uted to its blockage of thromboxanes and prostaglandin production. However, low-
dose aspirin has been found to trigger production of beneficial, anti-inflammatory, and 
pro-resolution mediators by COX2, the aspirin-triggered resolvins, and lipoxins, thus 
alleviating inflammation via stimulating endogenous resolution mechanisms. It is possible 
that high-dose aspirin inhibits a range of anti-inflammatory lipid metabolites, some yet 
unidentified, which may account for some of its side effects.
Now, in a series of elegant experiments using genetic and pharmacological manipulation 
of endogenous 12-HHT levels, Liu et al. demonstrate for the first time that 12-HHT pro-
motes wound healing by accelerating keratinocyte migration via the BLT2 receptor, result-
ing in enhanced re-epithelialization in the skin. The 12-HHT/BLT2 axis induces keratinocyte 
migration and wound closure through NF-kB dependent up-regulation of TNF and matrix 
metalloproteinase 9 (MMP9). Remarkably, a synthetic BLT2 agonist accelerated wound 
closure in a mouse diabetes model. These pioneering studies by Liu et al. provide the first 
mechanistic insight into the deleterious effect of high-dose aspirin on wound healing.
These results suggest a direct anti-inflammatory role of BLT2 that is distinct from 
the proinflammatory roles of BLT1. Liu et al. offer a mechanistic rationale for evaluating 
BLT agonists as novel therapeutics to accelerate wound healing. Based on these exciting 
results, the largely unexplored lipid autacoid 12-HHT/BLT2 axis should now be evaluated 
as potential therapeutic targets in other inflammation-associated diseases such as cancer, 
atherosclerosis, and sepsis.
Liu, M., et al. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20132063.
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The 12-HHT/BLT2 axis promotes wound 
healing by accelerating keratinocyte 
migration through NF-kB  –dependent 
up-regulation of TNF and MMP9.
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A designer approach to adjuvant development may be required to improve upon natural immunity, to 
reliably induce protective immunity to pathogens against which we have no effective vaccines, and to 
develop effective therapeutic vaccines for cancer and other types of disease for which current therapies 
are inadequate.
The quest to design biological structures for adjuvant use began many years ago, exemplified by the 
work of Edgar Ribi to dissect the adjuvant activity from LPS while eliminating the toxic components. 
More recent work has defined the precise structure–function aspects of adjuvant binding to toll-like 
receptors (TLRs) using synthetic chemical entities. However, most adjuvants in current use, including 
those categorized loosely as “alum,” are not homogeneous and their composition is not well characterized. 
The effects of chemical composition, charge, particle size, shape, and particle association (e.g., encapsulation 
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and internalization versus surface binding) all influence immunological responses, 
but precise, controlled studies with defined compositions and controlled vari-
ables, using innate responses ex vivo to predict adaptive responses in vivo, are 
relatively few.
The study by Williams et al. in this issue uses immune response readouts from 
cultured human and mouse dendritic cells to mathematically model the relationship 
between adjuvant materials and the immune responses they induce, adding a rational 
approach to the concept that “immunity can be determined purely by chemistry." 
The authors used physically and chemically defined structures that resemble alum 
(layered double hydroxides [LDH]; see figure). The modeling predicted that varying 
three key physicochemical properties of LDHs (the ionic radius, the c-parameter 
[the interlayer spacing within the LDH], and the zeta potential [the magnitude of 
the electrical charge of the layer around the LDH particle]; see figure) would influ-
ence innate and adaptive responses in a predictable manner. These predictions 
were tested and verified in mouse immunization studies and ex vivo studies on 
human macrophages.
While it may still be some way off, this novel mathematical approach to predicting 
the immune responses induced by candidate crystalline adjuvants offers the exciting 
possibility of rational design of superior adjuvants.
Williams, G.R., et al. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20131768.
Schematic of a layered double hydroxide 
showing the positively charged cation layers 
(red/blue circles) and negatively charged 
anion layers (green circles) sandwiched 
between two layers of water molecules.
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In this issue, Liu et al. provide compelling evidence for a novel mechanism by which pathogenic bacteria can 
acquire iron from mammalian cells.
Iron is an essential nutrient for almost all organisms due to its central role in many enzymatic processes, 
mitochondrial respiration, and DNA synthesis. Most microbes are highly dependent on a sufficient supply of 
iron to secure their growth, and they can acquire this essential nutrient by multiple pathways. One of these 
acquisition strategies is via the release of bacterial siderophores, which capture iron in the environment and 
are then taken up by microbes.
Mammalian cells also produce a siderophore, which is presumably used for intracellular and transcel-
lular iron shuttling. Liu et al. found that this mammalian siderophore, 2,5-dihydroxybenzoic acid (2,5-DHBA), 
can be taken up by bacteria and used as a source for iron. Synthesis of 2,5-DHBA was reduced upon bacterial 
infection, and knock out of this mammalian siderophore resulted in increased resistance of mice to infec-
tion with E. coli. Importantly, mammalian immune cells also produce the peptide lipocalin-2 in response to infection, which 
sequesters both bacterial and mammalian siderophores. Thus, combined down-regulation of 2,5-DHBA and up-regulation 
of lipocalin-2 restricts iron availability for microbes, resulting in a beneficial 
infection outcome.
Given the importance of iron for microbial growth and for antimicrobial immune 
defenses, the struggle for control over iron availability is a central battlefield that may 
decide the fate of an infection. This study describes a novel pathway by which bac-
teria steal the nutrient iron from the mammalian host to secure their own growth and 
pathogenicity. Targeting both mammalian and microbial iron homeostasis is an attrac-
tive approach to tackle iron availability for microbes and to treat infections, a strategy 
first studied in malaria and hepatitis C virus infection with varying outcomes, but not 
yet in bacterial infections in humans. However, it has to be kept in mind that restricting 
iron availability for extracellular microbes may favor the growth of pathogens residing 
within cells and vice versa. Moreover, we need to gain further insights into the role 
of the mammalian siderophores in orchestrating mammalian iron homeostasis 
under normal and inflammatory or infectious conditions, and how the pharmacological inhibition of 2,5-DHBA synthesis will 
impact host immune function, erythropoiesis, and iron-dependent cellular processes.
Liu, Z., et al. 2014. J. Exp. Med. http://dx.doi.org/10.1084/jem.20132629.
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2,5-DHBA–deficient mice are resistant to 
E. coli infection.
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